| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 28, 2026 | Tenpoint Therapeutics | $85.0M Series B | British Business Bank, EQT, Hillhouse Investment, Janus Henderson Investors | AdBio partners, Eight Roads Ventures, EQT Life Sciences, Qiming Venture Partners USA, Sofinnova Partners, Wille Finance |